Immediate Impact
34 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Alberto Cafferata being referenced
Diagnosis and Management of Statin Intolerance
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alberto Cafferata | 62 | 25 | 4 | 51 | 7 | 130 | |
| Jae‐Moon Yun | 58 | 48 | 11 | 50 | 7 | 242 | |
| Lamija Ferhatbegović | 56 | 38 | 6 | 39 | 9 | 115 | |
| Yadong Yang | 76 | 69 | 2 | 45 | 7 | 167 | |
| Y Henkin | 40 | 36 | 17 | 45 | 10 | 178 | |
| Sharon Kean | 42 | 21 | 15 | 42 | 8 | 185 | |
| Frances E. Broyles | 113 | 41 | 1 | 107 | 10 | 207 | |
| Sandra T. Foo | 108 | 26 | 3 | 64 | 4 | 192 | |
| Juan José de la Cruz | 27 | 41 | 12 | 46 | 7 | 102 | |
| Courtney Page | 41 | 30 | 11 | 42 | 11 | 94 | |
| E. Bilianou | 32 | 19 | 2 | 42 | 8 | 89 |
All Works
Loading papers...